Total Payments
$611,027
2024 Payments
$124,198
Companies
32
Transactions
885
Medicare Patients
3,644
Medicare Billing
$659,548
Payment Breakdown by Category
Consulting$430,206 (70.4%)
Other$106,455 (17.4%)
Travel$60,209 (9.9%)
Food & Beverage$14,157 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $430,206 | 112 | 70.4% |
| Honoraria | $86,015 | 23 | 14.1% |
| Travel and Lodging | $60,209 | 355 | 9.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,440 | 5 | 3.3% |
| Food and Beverage | $14,157 | 390 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $605,074 | 797 | $0 (2024) |
| Abbott Laboratories | $2,206 | 9 | $0 (2020) |
| Vertos Medical, Inc. | $957.36 | 7 | $0 (2021) |
| Becton, Dickinson and Company | $450.00 | 1 | $0 (2024) |
| Nevro Corp. | $336.48 | 10 | $0 (2022) |
| Medtronic USA, Inc. | $312.07 | 5 | $0 (2020) |
| Boston Scientific Corporation | $238.48 | 5 | $0 (2022) |
| NuVasive, Inc. | $176.06 | 1 | $0 (2019) |
| Fidia Pharma USA Inc. | $170.30 | 1 | $0 (2023) |
| ASSERTIO THERAPEUTICS, Inc. | $139.00 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124,198 | 157 | Pacira Pharmaceuticals Incorporated ($123,509) |
| 2023 | $177,175 | 237 | Pacira Pharmaceuticals Incorporated ($176,853) |
| 2022 | $120,728 | 177 | Pacira Pharmaceuticals Incorporated ($120,430) |
| 2021 | $125,253 | 183 | Pacira Pharmaceuticals Incorporated ($125,007) |
| 2020 | $57,619 | 75 | Pacira Pharmaceuticals Incorporated ($55,262) |
| 2019 | $5,726 | 43 | Pacira Pharmaceuticals Incorporated ($4,014) |
| 2018 | $245.34 | 9 | Abbott Laboratories ($162.13) |
| 2017 | $83.60 | 4 | Depomed, Inc. ($43.82) |
All Payment Transactions
885 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $106.53 | General |
| Category: Pain Management | ||||||
| 12/31/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $22.56 | General |
| Category: Pain Management | ||||||
| 12/24/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Honoraria | Cash or cash equivalent | $3,380.00 | General |
| Category: Pain Management | ||||||
| 12/03/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Pain Management | ||||||
| 11/26/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Consulting Fee | Cash or cash equivalent | $1,820.00 | General |
| Category: Pain Management | ||||||
| 11/21/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $149.56 | General |
| Category: Pain Management | ||||||
| 11/10/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | In-kind items and services | $202.14 | General |
| Category: Pain Management | ||||||
| 11/10/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $76.09 | General |
| Category: Pain Management | ||||||
| 11/10/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $59.70 | General |
| Category: Pain Management | ||||||
| 11/10/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $58.57 | General |
| Category: Pain Management | ||||||
| 11/10/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $53.24 | General |
| Category: Pain Management | ||||||
| 11/10/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Pain Management | ||||||
| 11/09/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | In-kind items and services | $217.14 | General |
| Category: Pain Management | ||||||
| 11/09/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $121.38 | General |
| Category: Pain Management | ||||||
| 10/29/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
| Category: Pain Management | ||||||
| 10/23/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $14.46 | General |
| 10/21/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $35.50 | General |
| 10/21/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $18.58 | General |
| 10/19/2024 | Becton, Dickinson and Company | HemoSphere (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Hemodynamic Monitoring | ||||||
| 10/19/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $37.80 | General |
| Category: Pain Management | ||||||
| 10/01/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Consulting Fee | Cash or cash equivalent | $5,720.00 | General |
| Category: Pain Management | ||||||
| 10/01/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $1,040.00 | General |
| Category: Pain Management | ||||||
| 10/01/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $298.48 | General |
| Category: Pain Management | ||||||
| 10/01/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $262.08 | General |
| Category: Pain Management | ||||||
| 10/01/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $154.86 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 895 | 1,815 | $1.3M | $167,440 |
| 2022 | 20 | 914 | 1,946 | $1.3M | $182,229 |
| 2021 | 15 | 1,004 | 1,883 | $1.3M | $190,711 |
| 2020 | 18 | 831 | 1,540 | $1.1M | $119,168 |
Total Patients
3,644
Total Services
7,184
Medicare Billing
$659,548
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 747 | $298,800 | $84,491 | 28.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 54 | 67 | $149,812 | $16,273 | 10.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 48 | 54 | $110,495 | $12,620 | 11.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $49,800 | $12,009 | 24.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 24 | 34 | $114,513 | $7,398 | 6.5% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 47 | 53 | $66,515 | $5,634 | 8.5% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 57 | 92 | $46,184 | $4,923 | 10.7% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 30 | 39 | $59,500 | $4,280 | 7.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 25 | 35 | $59,236 | $3,985 | 6.7% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2023 | 12 | 15 | $86,250 | $3,715 | 4.3% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 19 | 57 | $74,827 | $3,139 | 4.2% |
| 64447 | Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | Office | 2023 | 12 | 16 | $31,644 | $1,809 | 5.7% |
| 64999 | Other procedure on nervous system | Facility | 2023 | 11 | 11 | $19,338 | $1,633 | 8.4% |
| 64418 | Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | Office | 2023 | 17 | 17 | $22,590 | $1,424 | 6.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 127 | 215 | $5,160 | $1,306 | 25.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 19 | $9,538 | $875.90 | 9.2% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 13 | 16 | $12,048 | $804.76 | 6.7% |
| 64447 | Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | Facility | 2023 | 13 | 13 | $38,676 | $661.71 | 1.7% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 16 | 16 | $8,032 | $437.92 | 5.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 43 | 216 | $1,296 | $21.07 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 239 | 819 | $327,600 | $93,508 | 28.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 54 | 67 | $149,812 | $17,181 | 11.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 44 | 45 | $92,414 | $11,018 | 11.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $40,800 | $10,565 | 25.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 27 | 36 | $128,576 | $8,581 | 6.7% |
About Dr. Gary Schwartz, M.D
Dr. Gary Schwartz, M.D is a Pain Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2010. The National Provider Identifier (NPI) number assigned to this provider is 1336464593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Schwartz, M.D has received a total of $611,027 in payments from pharmaceutical and medical device companies, with $124,198 received in 2024. These payments were reported across 885 transactions from 32 companies. The most common payment nature is "Consulting Fee" ($430,206).
As a Medicare-enrolled provider, Schwartz has provided services to 3,644 Medicare beneficiaries, totaling 7,184 services with total Medicare billing of $659,548. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Anesthesiology
- Location Brooklyn, NY
- Active Since 03/31/2010
- Last Updated 02/24/2012
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336464593
Products in Payments
- Exparel (Drug) $350,737
- Iovera (Device) $192,164
- EXPAREL (Drug) $57,432
- Iovera System (Device) $2,888
- CentriMag (Device) $1,900
- IOVERA SYSTEM (Device) $1,845
- mild Device Kit (Device) $957.36
- HemoSphere (Device) $450.00
- Senza Spinal Cord Stimulation System (Device) $228.14
- Octrode SCS Leads (Device) $197.02
- Bendini (Device) $176.06
- HYMOVIS (Device) $170.30
- General - Pain Management (Device) $159.27
- MazorX - Renaissance (Device) $125.21
- Omnia (Device) $108.34
- DIVERGENCE-L (Device) $101.67
- Intracept (Device) $81.71
- Penta SCS Leads (Device) $78.14
- Gralise (Drug) $71.23
- Zipsor (Drug) $67.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Brooklyn
Dr. David Rosenblum, Md, MD
Pain Medicine — Payments: $93,379
Pain Medicine $93,379
Dr. Thomas Del Guercio, M.d, M.D
Pain Medicine — Payments: $18,192
Pain Medicine $18,192
Dr. Leonid Reyfman, Md, MD
Pain Medicine — Payments: $15,288
Pain Medicine $15,288
Jacob Peacock, Md, MD
Pain Medicine — Payments: $8,673
Pain Medicine $8,673
Dr. Jonathan Hirsch, Md, MD
Pain Medicine — Payments: $6,462
Pain Medicine $6,462
Tatyana Kisina, Md, MD
Pain Medicine — Payments: $6,113
Pain Medicine $6,113